Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neelu Puri

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Cancer Letters|September 18, 2013
Non-small cell lung cancer is susceptible to induction of DNA damage responses and inhibition of angiogenesis by telomere overhang oligonucleotidesNeelu Puri, Ryan T Pitman, Richard E Mulnix, et al.
Plos One|November 14, 2013
Alternative signaling pathways as potential therapeutic targets for overcoming EGFR and c-Met inhibitor resistance in non-small cell lung cancerJason T Fong, Ryan J Jacobs, David N Moravec, et al.
Biomedicines|July 29, 2025
The Role of Fat Mass and Obesity-Associated (FTO) Gene in Non-Small Cell Lung Cancer Tumorigenicity and EGFR Tyrosine Kinase Inhibitor ResistanceAayush Rastogi, Rong Qiu, Rachel Campoli, et al.
Anti-Cancer Agents in Medicinal Chemistry|February 3, 2015
Current Molecularly Targeting Therapies in NSCLC and MelanomaSupriya Rajanna, Ichwaku Rastogi, Luke Wojdyla, et al.
The Journal of Investigative Dermatology|December 6, 2017
Mechanism of Action of G-Quadruplex-Forming Oligonucleotide Homologous to the Telomere Overhang in MelanomaGagan Chhabra, Luke Wojdyla, Mark Frakes, et al.
Cancers|July 6, 2018
Current Molecular-Targeted Therapies in NSCLC and Their Mechanism of ResistanceZachary Schrank, Gagan Chhabra, Leo Lin, et al.
Cancers|July 14, 2023
PRMT-1 and p120-Catenin as EMT Mediators in Osimertinib Resistance in NSCLCKavya Sri Racherla, Katrina Dovalovsky, Meet Patel, et al.
Oncotargets and Therapy|January 1, 2014
hnRNP C1/C2 and Pur-beta proteins mediate induction of senescence by oligonucleotides homologous to the telomere overhangRichard E Mulnix, Ryan T Pitman, Allison Retzer, et al.
Current Pharmaceutical Design|July 1, 2014
Oligonucleotides and G-quadruplex stabilizers: targeting telomeres and telomerase in cancer therapyZachary Crees, Jennifer Girard, Zechary Rios, et al.
Cells|June 19, 2024
The Effects of Smoking on Telomere Length, Induction of Oncogenic Stress, and Chronic Inflammatory Responses Leading to AgingShreya Deb, Joseph Berei, Edward Miliavski, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Cancer Letters|September 18, 2013
Non-small cell lung cancer is susceptible to induction of DNA damage responses and inhibition of angiogenesis by telomere overhang oligonucleotidesNeelu Puri, Ryan T Pitman, Richard E Mulnix, et al.
Plos One|November 14, 2013
Alternative signaling pathways as potential therapeutic targets for overcoming EGFR and c-Met inhibitor resistance in non-small cell lung cancerJason T Fong, Ryan J Jacobs, David N Moravec, et al.
Biomedicines|July 29, 2025
The Role of Fat Mass and Obesity-Associated (FTO) Gene in Non-Small Cell Lung Cancer Tumorigenicity and EGFR Tyrosine Kinase Inhibitor ResistanceAayush Rastogi, Rong Qiu, Rachel Campoli, et al.
Anti-Cancer Agents in Medicinal Chemistry|February 3, 2015
Current Molecularly Targeting Therapies in NSCLC and MelanomaSupriya Rajanna, Ichwaku Rastogi, Luke Wojdyla, et al.
The Journal of Investigative Dermatology|December 6, 2017
Mechanism of Action of G-Quadruplex-Forming Oligonucleotide Homologous to the Telomere Overhang in MelanomaGagan Chhabra, Luke Wojdyla, Mark Frakes, et al.
Cancers|July 6, 2018
Current Molecular-Targeted Therapies in NSCLC and Their Mechanism of ResistanceZachary Schrank, Gagan Chhabra, Leo Lin, et al.
Cancers|July 14, 2023
PRMT-1 and p120-Catenin as EMT Mediators in Osimertinib Resistance in NSCLCKavya Sri Racherla, Katrina Dovalovsky, Meet Patel, et al.
Oncotargets and Therapy|January 1, 2014
hnRNP C1/C2 and Pur-beta proteins mediate induction of senescence by oligonucleotides homologous to the telomere overhangRichard E Mulnix, Ryan T Pitman, Allison Retzer, et al.
Current Pharmaceutical Design|July 1, 2014
Oligonucleotides and G-quadruplex stabilizers: targeting telomeres and telomerase in cancer therapyZachary Crees, Jennifer Girard, Zechary Rios, et al.
Cells|June 19, 2024
The Effects of Smoking on Telomere Length, Induction of Oncogenic Stress, and Chronic Inflammatory Responses Leading to AgingShreya Deb, Joseph Berei, Edward Miliavski, et al.
Pageof 4